Global support for a quality solution

We lead innovation in peptide API’s to the benefit of millions of patients

Contact us

Market leader in peptide API manufacturing and services

PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API). 

Media releases

PolyPeptide signs scientific collaboration agreement

31 Oct 2023 - Strasbourg, 31 October 2023 – PolyPeptide today announced the signing of a collaboration agreement with the Peptide Sciences Laboratory of the University of KwaZulu-Natal (UKZN) in […]

Read more
Media releases

PolyPeptide secures revolving credit facility

2 Oct 2023 - Baar, 2 October 2023 – PolyPeptide Group AG (SIX: PPGN) announces the signing of a revolving credit facility agreement with Credit Suisse, Danske Bank and Zürcher […]

Read more

PolyPeptide video

PolyPeptide Group - Ahead on green peptide chemistry